Investment Summary |
|
|---|---|
| Date | 2020-06-01 |
| Target | iTel Networks |
| Sector | Communications |
| Investor(s) | Anzu Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 2014 |
| PE ASSETS | 1.0B USD |
| Size | Middle-Market |
| Type | Sector Agnostic |
Anzu Partners is a venture capital and private equity firm that looks to develop and commercialize technological advancements in manufacturing, materials, monitoring/measurement, and modeling. This includes 3D printing, robotics, nanotechnology, composites, sensors, AI, and analytics. Anzu Partners was formed in 2014 and is headquartered in Boston, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 16 of 36 |
| Sector: Communications M&A | 1 of 1 |
| Type: Venture M&A Deals | 16 of 32 |
| State: British Columbia M&A | 1 of 1 |
| Country: Canada M&A | 2 of 3 |
| Year: 2020 M&A | 2 of 9 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-02-25 |
NTx
Rio Rancho, New Mexico, United States NTx develops a cell-free process to produce biologics of high purity, stability, and low cost. The firm has the world’s first fully recombinant cell-free system based on thermophile strains and using continuous flow bioreactors. NTx was founded in 2015 and is based in Rio Rancho, New Mexico. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-06-09 |
BioFlyte
Albuquerque, New Mexico, United States BioFlyte is a biodefense and microbial identification company that is commercializing a revolutionary new class of fieldable biological threat collection, detection, and identification solutions. BioFlyte is based in Albuquerque, New Mexico. |
Buy | - |